
Company valuation, historical trends, and peer comparisons.
According to Arbutus Biopharma Corp’s latest financial reports and current stock price. The company's current Enterprise Value is 810.67M. This represents a change of -8.53% compared to the average of 886.28M of the last 4 quarters.
The mean historical Enterprise Value of Arbutus Biopharma Corp over the last ten years is 343.54M. The current 810.67M Enterprise Value has changed 135.98% with respect to the historical average. Over the past ten years (40 quarters), ABUS's Enterprise Value was at its highest in in the June 2026 quarter at 932.31M. The Enterprise Value was at its lowest in in the September 2019 quarter at 370.76K.
Average
343.54M
Median
281.21M
Minimum
118.58M
Maximum
907.77M
Discovering the peaks and valleys of Arbutus Biopharma Corp Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 234.36%
Maximum Annual Enterprise Value = 907.77M
Minimum Annual Increase = -25.50%
Minimum Annual Enterprise Value = 118.58M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 907.77M | 57.40% |
| 2024 | 576.73M | 45.15% |
| 2023 | 397.34M | 19.15% |
| 2022 | 333.46M | 3.27% |
| 2021 | 322.91M | 34.83% |
| 2020 | 239.50M | 83.84% |
| 2019 | 130.28M | -25.50% |
| 2018 | 174.87M | -25.24% |
| 2017 | 233.91M | 97.26% |
| 2016 | 118.58M | 234.36% |
The current Enterprise Value of Arbutus Biopharma Corp (ABUS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
627.28M
5-year avg
507.64M
10-year avg
343.54M
Arbutus Biopharma Corp’s Enterprise Value is greater than Assembly Biosciences, Inc. (371.78M), greater than Aligos Therapeutics, Inc. (3.16M), greater than Enanta Pharmaceuticals, Inc. (326.52M), greater than Atea Pharmaceuticals, Inc. (250.31M), less than Vir Biotechnology, Inc. (1.72B), less than Alnylam Pharmaceuticals, Inc. (20.67B), less than Arrowhead Pharmaceuticals, Inc. (9.38B), greater than Benitec Biopharma Inc. (117.35M), less than Silence Therapeutics plc (862.38M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 371.78M | $401.71M | |
| 3.16M | $30.04M | |
| 326.52M | $304.29M | |
| 250.31M | $326.43M | |
| 1.72B | $1.91B | |
| 20.67B | $21.16B | |
| 9.38B | $8.57B | |
| 117.35M | $296.56M | |
| 862.38M | $934.33M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Arbutus Biopharma Corp using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Arbutus Biopharma Corp or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Arbutus Biopharma Corp's Enterprise Value?
What is the highest Enterprise Value for Arbutus Biopharma Corp (ABUS)?
What is the 3-year average Enterprise Value for Arbutus Biopharma Corp (ABUS)?
What is the 5-year average Enterprise Value for Arbutus Biopharma Corp (ABUS)?
How does the current Enterprise Value for Arbutus Biopharma Corp (ABUS) compare to its historical average?